We further observed that MFN2 OE enhanced the proportion of cycling Ki67 and DAPI double-positive cells, and decreased CFSE retention compared to the control in AML PDX cells ex vivo (Fig. 3K and Supplementary Fig. S3J). This evidence concerns the gene MFN2 and acute myeloid leukemia.